Chapter
ESPECIFIC MODALITIES OF SURGICAL TREATMENT
Chapter 3: RECENT DEVELOPMENTS IN THE IMAGING OF OSTEOSARCOMA
RESPONSE TO TREATMENT: QUALITATIVE
QUANTITATIVE APPROACHES TO EVALUATING TUMOR RESPONSE
DYNAMIC CONTRAST ENHANCED MRI (DCE-MRI)
IMAGE-GUIDED INTERVENTION
POST-TREATMENT IMAGING: TREATMENT RELATED FINDINGS
SURVEILLANCE FOR RECURRENCE
Chapter 4: PROMISING THERAPEUTIC APPROACHES FOR OSTEOSARCOMA TARGETING MIDKINE
SEARCH STRATEGY AND SELECTION CRITERIA
Chapter 5: INORGANIC PHOSPHATE AS A NOVEL SIGNALING MOLECULE: ITS POTENTIAL USE IN THE OSTEOSARCOMA THERAPY
Chapter 6: MICRORNAS IN THE PATHOBIOLOGY OF OSTEOSARCOMA
INTRODUCTION: OSTEOSARCOMA, MICRORNAS, AND IMPROVING TREATMENT
ROLE OF MIRNAS IN OSTEOSARCOMA
THE PERTURBATION OF 14Q32 MIR-CMYC-MIR-17-92 NETWORK IN OSTEOSARCOMA
PROGNOSTIC MARKERS IN OSTEOSARCOMA
14Q32 MIRNAS ARE POTENTIAL PROGNOSTIC MARKERS
CURRENT OSTEOSARCOMA DRUGS AND TREATMENTS
MINNELIDE AND OSTEOSARCOMA
Chapter 7: EMERGING SIGNALING PATHWAYS FOR FUTURE THERAPIES IN OSTEOSARCOMA: WNT, NOTCH AND HEDGEHOG SIGNALING
ACKNOWLEDGEMENTS, FUNDING, AND CONFLICTS OF INTEREST
Chapter 8: EMERGING ROLES OF PROTEIN KINASES IN OSTEOSARCOMA AND POTENTIAL NOVEL THERAPEUTIC STRATEGIES
3. PROTEIN KINASE INVOLVEMENT IN OSTEOSARCOMA
4. ANGIOGENIC PATHWAY (VEGF PATHWAY) AS A THERAPEUTIC TARGET IN OSTEOSARCOMA
5. EXPLORING OTHER NOVEL KINASE-BASED THERAPEUTIC TARGETS IN OSTEOSARCOMA
Chapter 9: CLINICAL TRIALS FOR OSTEOSARCOMA
CURRENT STANDARD OF CARE FOR OSTEOSARCOMA
Osteosarcoma: Symptoms, Diagnosis and Treatment Options
( Cancer Etiology, Diagnosis and Treatments )
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.